NASDAQ:BWAY - US10501L1061 - ADR
The current stock price of BWAY is 15.56 USD. In the past month the price increased by 35.66%. In the past year, price increased by 96.71%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.07 | 230.89B | ||
ISRG | INTUITIVE SURGICAL INC | 58.79 | 169.67B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.28 | 156.32B | ||
SYK | STRYKER CORP | 30.46 | 149.64B | ||
MDT | MEDTRONIC PLC | 16.78 | 119.05B | ||
BDX | BECTON DICKINSON AND CO | 13.52 | 55.31B | ||
IDXX | IDEXX LABORATORIES INC | 53.88 | 51.77B | ||
EW | EDWARDS LIFESCIENCES CORP | 31.65 | 47.75B | ||
RMD | RESMED INC | 28.74 | 40.19B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.82 | 33.66B | ||
DXCM | DEXCOM INC | 44.32 | 29.55B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 16.42 | 26.56B |
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
BRAINSWAY LTD-ADR
16 Hartum Street Rad Tower, 14Th Floor, Har HaHotzvim
JERUSALEM 9777518 IL
CEO: Christopher R. von Jako
Employees: 120
Phone: 97225813140
The current stock price of BWAY is 15.56 USD. The price increased by 1.43% in the last trading session.
The exchange symbol of BRAINSWAY LTD-ADR is BWAY and it is listed on the Nasdaq exchange.
BWAY stock is listed on the Nasdaq exchange.
7 analysts have analysed BWAY and the average price target is 0.1 USD. This implies a price decrease of -99.38% is expected in the next year compared to the current price of 15.56. Check the BRAINSWAY LTD-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BRAINSWAY LTD-ADR (BWAY) has a market capitalization of 294.11M USD. This makes BWAY a Micro Cap stock.
BRAINSWAY LTD-ADR (BWAY) currently has 120 employees.
BRAINSWAY LTD-ADR (BWAY) has a support level at 12.62. Check the full technical report for a detailed analysis of BWAY support and resistance levels.
The Revenue of BRAINSWAY LTD-ADR (BWAY) is expected to grow by 16.02% in the next year. Check the estimates tab for more information on the BWAY EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BWAY does not pay a dividend.
BRAINSWAY LTD-ADR (BWAY) will report earnings on 2025-11-10, before the market open.
The PE ratio for BRAINSWAY LTD-ADR (BWAY) is 11.19. This is based on the reported non-GAAP earnings per share of 1.39 and the current share price of 15.56 USD. Check the full fundamental report for a full analysis of the valuation metrics for BWAY.
The outstanding short interest for BRAINSWAY LTD-ADR (BWAY) is 0.52% of its float. Check the ownership tab for more information on the BWAY short interest.
ChartMill assigns a technical rating of 10 / 10 to BWAY. When comparing the yearly performance of all stocks, BWAY is one of the better performing stocks in the market, outperforming 95.02% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to BWAY. While BWAY has a great health rating, its profitability is only average at the moment.
Over the last trailing twelve months BWAY reported a non-GAAP Earnings per Share(EPS) of 1.39. The EPS increased by 1178.38% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 9.01% | ||
ROA | 3.91% | ||
ROE | 6.14% | ||
Debt/Equity | 0.07 |
7 analysts have analysed BWAY and the average price target is 0.1 USD. This implies a price decrease of -99.38% is expected in the next year compared to the current price of 15.56.
For the next year, analysts expect an EPS growth of 58.83% and a revenue growth 16.02% for BWAY